Core Insights - The 31st China International Medical Instrument and Equipment Exhibition showcased over 300 companies and highlighted innovations in various medical fields, including AI healthcare solutions [1] - The "Xihe No.1" medical AI model was officially launched, developed by a collaboration between Peking University Third Hospital, Peking University AI Institute, and Boya Quanjian Technology, with a focus on enhancing healthcare in Africa [2][1] Group 1: AI Model Development - The "Xihe No.1" model took nearly 10 years to develop, utilizing 1 million real clinical cases to create a model with over 100 billion parameters, achieving a medical knowledge coverage rate of 98% and precision rate above 90% [2][3] - The model's training data comes from 18 medical institutions, ensuring high reliability and ethical compliance, with all data processed and labeled by clinical doctors [3] Group 2: Differentiation Strategy - The model differentiates itself by relying on rigorous clinical data rather than internet-sourced information, which may lack clinical validation [3] - The accuracy of "Xihe No.1" is significantly higher than models trained on less reliable data, with an error output rate that is extremely low [3] Group 3: Demand-Driven R&D - The development philosophy of "Xihe No.1" is centered on addressing clinical needs rather than merely applying technology, which is seen as crucial for effective AI healthcare solutions [4] - The model aims to tackle specific clinical challenges, such as high misdiagnosis rates and inadequate diagnostic capabilities in primary care settings [4][5] Group 4: Commercialization Path - The commercialization strategy involves a "1+N" hierarchical diagnosis model, validating the technology in top-tier hospitals before extending it to primary care facilities, thus addressing resource shortages in grassroots healthcare [5]